Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Wolman-Erkrankung

Die Wolman-Erkrankung ist eine bereits im Kleinkindesalter einsetzende schwer verlaufende autosomal rezessive Erkrankung. Die Erkrankung wird durch Mutationen der lysosomalen sauren Lipase ausgelöst. Durch den Mangel dieses Enzyms können Cholesterinester in den Lysosomen nicht mehr abgebaut werden und akkumulieren. Diese lysosomale Speicherkrankheit führt im weiteren zu einer Gewebs- und Organzerstörung besonders in der Leber und den Nebennieren. Betroffene überleben nicht das erste Lebensjahr, wenn nicht durch hematopoetische Stammzelltranplantation behandelt.

Management

Zur Therapie steht das Kanuma® (sebelipase alfa) zur Verfügung.

Gliederung

Lysosomale Speicherkrankheiten
Chediak-Higashi-Syndrom
Cystinose
Infantile Sialinsäurespeicherkrankheit
Mangel an lysosomaler saurer Lipase
Morbus Fabry
Salla Erkrankung
Wolman-Erkrankung
LIPA

Referenzen:

1.

Konno T et al. (1966) Wolman's disease: the first case in Japan.

external link
2.

Chatterjee S et al. (1986) Evaluation of urinary cells in acid cholesteryl ester hydrolase deficiency.

external link
3.

Sloan HR et al. (1972) Enzyme deficiency in cholesteryl ester storage idisease.

external link
4.

None (1971) Histochemical detection of the enzyme deficiency in blood films in Wolman's disease.

external link
5.

Lake BD et al. (1970) Wolman's disease: deficiency of E600-resistant acid esterase activity with storage of lipids in lysosomes.

external link
6.

Lough J et al. (1970) Wolman's disease. An electron microscopic, histochemical, and biochemical study.

external link
7.

Young EP et al. (1970) Deficiency of acid esterase activity in Wolman's disease.

external link
8.

Schiff L et al. (1968) Hepatic cholesterol ester storage disease, a familial disorder. I. Clinical aspects.

external link
9.

Kahana D et al. (1968) Primary familial xanthomatosis with adrenal involvement (Wolman's disease). Report of a further case with nervous system involvement and pathogenetic considerations.

external link
10.

Marshall WC et al. (1969) Wolman's disease. A rare lipidosis with adrenal calcification.

external link
11.

Patrick AD et al. (1969) Deficiency of an acid lipase in Wolman's disease.

external link
12.

Koch G et al. (1981) Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19.

external link
13.

Hoeg JM et al. (1984) Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency.

external link
14.

Besley GT et al. (1984) Cholesterol ester storage disease in an adult presenting with sea-blue histiocytosis.

external link
15.

Burton BK et al. (1981) Acid lipase cross-reacting material in Wolman disease and cholesterol ester storage disease.

external link
16.

Christomanou H et al. (1981) Prenatal monitoring for Wolman's disease in a pregnancy at risk: first case in the Federal Republic of Germany.

external link
17.

Schaub J et al. (1980) Wolman's disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification.

external link
18.

Du H et al. (1998) Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.

external link
19.

Du H et al. (2001) Enzyme therapy for lysosomal acid lipase deficiency in the mouse.

external link
20.

WOLMAN M et al. (1961) Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant.

external link
21.

CROCKER AC et al. (1965) WOLMAN'S DISEASE: THREE NEW PATIENTS WITH A RECENTLY DESCRIBED LIPIDOSIS.

external link
22.

Burton BK et al. (2015) A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.

external link
23.

Desai PK et al. (1987) Cholesteryl ester storage disease: pathologic changes in an affected fetus.

external link
24.

Anderson RA et al. (1991) Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases.

external link
25.

Warner TG et al. (1980) Separation and characterization of the acid lipase and neutral esterases from human liver.

external link
26.

Muntoni S et al. (1995) Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).

external link
27.

Aslanidis C et al. (1994) Genomic organization of the human lysosomal acid lipase gene (LIPA).

external link
28.

Anderson RA et al. (1994) Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.

external link
29.

Klima H et al. (1993) A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

external link
30.

Anderson RA et al. (1993) In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3.

external link
31.

Muntoni S et al. (1996) A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations.

external link
32.

Maslen CL et al. (1995) Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease.

external link
33.

Aslanidis C et al. (1996) Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

external link
34.

Pagani F et al. (1996) Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease.

external link
35.

Fujiyama J et al. (1996) A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease.

external link
36.

Lee TM et al. (2011) Intragenic deletion as a novel type of mutation in Wolman disease.

external link
37.

Coates PM et al. (1978) Prenatal diagnosis of Wolman disease.

external link
38.

Byrd JC et al. (1979) Wolman's disease: ultrastructural evidence of lipid accumulation in central and peripheral nervous systems.

external link
39.

Beaudet AL et al. (1977) Cholesterol ester storage disease: clinical, biochemical, and pathological studies.

external link
40.

Röyttä M et al. (1992) Wolman disease: morphological, clinical and genetic studies on the first Scandinavian cases.

external link
41.

Yokoyama S et al. (1992) Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.

external link
42.

Di Bisceglie AM et al. (1990) Cholesteryl ester storage disease: hepatopathology and effects of therapy with lovastatin.

external link
43.

Cagle PT et al. (1986) Pulmonary hypertension in an 18-year-old girl with cholesteryl ester storage disease (CESD)

external link
44.

OMIM.ORG article

Omim 278000 external link
45.

Orphanet article

Orphanet ID 75233 external link
46.

Wikipedia Artikel

Wikipedia DE (Wolman-Krankheit) external link
Update: 14. August 2020
Copyright © 2005-2024 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz | Impressum